26.28
price up icon1.82%   0.47
pre-market  시장 영업 전:  26.14   -0.14   -0.53%
loading

Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스

pulisher
05:07 AM

How to use a screener to detect Viking Therapeutics Inc. breakoutsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com

05:07 AM
pulisher
Sep 30, 2025

Applying Elliott Wave Theory to Viking Therapeutics Inc.July 2025 Review & AI Enhanced Trade Execution Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will Viking Therapeutics Inc. stock attract more institutional investors2025 Top Decliners & Technical Buy Zone Confirmations - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT - Yahoo Finance

Sep 30, 2025
pulisher
Sep 30, 2025

BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Why This Beaten-Down GLP-1 Stock Could Be a Steal - AOL.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why This Beaten-Down GLP-1 Stock Could Be a Steal - The Motley Fool

Sep 30, 2025
pulisher
Sep 30, 2025

What to expect from Viking Therapeutics Inc. in the next 30 days2025 Earnings Impact & Weekly High Momentum Picks - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

HC Wainwright & Co. Reiterates Viking Therapeutics (VKTX) Buy Recommendation - Nasdaq

Sep 29, 2025
pulisher
Sep 29, 2025

H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102 - 富途牛牛

Sep 29, 2025
pulisher
Sep 29, 2025

Viking Therapeutics: Promising Position in GLP-1 Market with Strategic Growth Potential - TipRanks

Sep 29, 2025
pulisher
Sep 29, 2025

VKTX: HC Wainwright Reiterates Buy Rating and Maintains Price Ta - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Viking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Is Viking Therapeutics Inc. reversing from oversold territoryWeekly Investment Report & Safe Capital Growth Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is Viking Therapeutics Inc. stock oversold or undervaluedInsider Selling & Verified Entry Point Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will Viking Therapeutics Inc. stock maintain momentum in 2025Watch List & Verified Momentum Stock Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Short interest data insights for Viking Therapeutics Inc.Trade Entry Summary & Stepwise Trade Execution Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Comparing Viking Therapeutics Inc. in custom built stock radarsWall Street Watch & Weekly Top Gainers Trade List - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Viking Therapeutics: Overdue For Gains (NASDAQ:VKTX) - Seeking Alpha

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Viking Therapeutics Inc 1VT stock priceResistance Breakout Alerts & Small Investment Capital Gains - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is Viking Therapeutics Inc a good long term investmentTechnical Analysis Insights & Low Risk Wealth Plans - Early Times

Sep 28, 2025
pulisher
Sep 27, 2025

Using flow based indicators on Viking Therapeutics Inc.July 2025 Outlook & Weekly Return Optimization Alerts - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Analyzing Viking Therapeutics Inc. with risk reward ratio chartsVolume Spike & Weekly Watchlist for Hot Stocks - newser.com

Sep 27, 2025
pulisher
Sep 26, 2025

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet? - MSN

Sep 26, 2025
pulisher
Sep 26, 2025

Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering. - MSN

Sep 26, 2025
pulisher
Sep 26, 2025

Viking Therapeutics: A Huge Reward Or A Total Loss (NASDAQ:VKTX) - Seeking Alpha

Sep 26, 2025
pulisher
Sep 26, 2025

Pfizer Acquires Metsera, Viking Therapeutics’ Prospects Attract Attention - NAI500

Sep 26, 2025
pulisher
Sep 25, 2025

Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors - sharewise.com

Sep 25, 2025
pulisher
Sep 25, 2025

Viking Therapeutics (NASDAQ:VKTX) Shares Down 5.8%Here's Why - MarketBeat

Sep 25, 2025
pulisher
Sep 25, 2025

Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up? - sharewise.com

Sep 25, 2025
pulisher
Sep 25, 2025

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - sharewise.com

Sep 25, 2025
pulisher
Sep 24, 2025

Viking Therapeutics Stock Surges on Promising Obesity Drug Pipeline - AD HOC NEWS

Sep 24, 2025
pulisher
Sep 24, 2025

Viking Therapeutics (NASDAQ:VKTX) Trading 6.6% HigherTime to Buy? - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Viking Therapeutics (NASDAQ:VKTX) Trading 7.4% HigherWhat's Next? - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Viking Therapeutics : September 2025 Corporate Presentation - MarketScreener

Sep 24, 2025
pulisher
Sep 24, 2025

Are Safety Concerns Around VK2735 Shaping Investor Perceptions of Viking Therapeutics (VKTX)? - simplywall.st

Sep 24, 2025
pulisher
Sep 24, 2025

Why Viking Therapeutics Stock Crashed Today - aol.com

Sep 24, 2025
pulisher
Sep 24, 2025

U.S. Capital Wealth Advisors LLC Purchases 27,795 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

Viking Therapeutics Shares Dip as Pfizer Chooses Rival Acquisition - AD HOC NEWS

Sep 23, 2025
pulisher
Sep 23, 2025

Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know - sharewise.com

Sep 23, 2025
pulisher
Sep 23, 2025

Pfizer’s $5B Bet on Metsera ($MTSR) vs Viking Therapeutics ($VKTX) - MSN

Sep 23, 2025
pulisher
Sep 23, 2025

Strs Ohio Invests $604,000 in Viking Therapeutics, Inc. $VKTX - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Viking Therapeutics at Bernstein Forum: Strategic Moves in Obesity Market - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Transcript : Viking Therapeutics, Inc. Presents at Bernstein 2nd Annual Global Healthcare Conference, Sep-23-2025 11 - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Viking Therapeutics at Bernstein Forum: Strategic Moves in Obesity Market By Investing.com - Investing.com UK

Sep 23, 2025
pulisher
Sep 23, 2025

Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ - Stocktwits

Sep 23, 2025
pulisher
Sep 23, 2025

Exchange Traded Concepts LLC Buys 20,296 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Viking Therapeutics: Oral Study Disappoints, Competitor Gets Bought Out (Rating Downgrade) - Seeking Alpha

Sep 22, 2025
pulisher
Sep 22, 2025

Why Viking Therapeutics Shares Are Climbing High - TipRanks

Sep 22, 2025
pulisher
Sep 22, 2025

BTIG Reiterates Buy Rating for Viking Therapeutics (VKTX) with $125 Target | VKTX Stock News - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125 - 富途牛牛

Sep 22, 2025
pulisher
Sep 22, 2025

Viking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from BTIG Research - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Viking Therapeutics: Strong Buy Rating Amid Strategic Positioning and Acquisition Potential in the Metabolic Disease Market - TipRanks

Sep 22, 2025
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
자본화:     |  볼륨(24시간):